(Q44000010)

28 November 2017

title

Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure (English)

1 reference

28 November 2017

1 reference

congestive heart failure

1 reference

Christian Zugck

1

1 reference

28 November 2017

Armin Haunstetter

2

1 reference

28 November 2017

Carsten Krüger

3

1 reference

28 November 2017

Robert Kell

4

1 reference

28 November 2017

Dieter Schellberg

5

1 reference

28 November 2017

Wolfgang Kübler

6

1 reference

28 November 2017

Markus Haass

7

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of the American College of Cardiology

28 November 2017

published in

1 reference

28 November 2017

volume

39

1 reference

28 November 2017

issue

10

1 reference

28 November 2017

page(s)

1615-1622

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Beta blocker treatment in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

The role of exercise-based prognosticating algorithms in the selection of patients for heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901840-5

7 January 2021

10.1016/S0735-1097(02)01840-5

Identifiers

DOI

1 reference

28 November 2017

1 reference